Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Sage Therapeutics Inc. logo

Sage Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

19.58
 
USD
  
0.10
  
(0.51%)
Optionable: Yes  Market Cap: 1,156 M  90-day average vol: 1,068,111

Previous close: 19.48  Open: 19.76  Bid: 18.5  Ask: 20.1
52 week range    
16.52   
   59.99
Peers   
RGLS / 
EGRX / 
HZNP / 
Last updated: Friday 1st December 2023
44
MarketXLS Rank
40
Value
46
Technical
47
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

SAGE Income Statement

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock2 M
Basic EPS total-13.3811.66-7.8-8.98
Basic weighted shares outstanding22 M28 M33 M38 M46 M51 M52 M59 M59 M
Depreciation-100000.0-100000.0-300000.0-500000.0-1 M-2 M-3 M-4 M-1 M
DepreciationAndAmortization-100000.0-100000.0-300000.0-500000.0-1 M-2 M-3 M-4 M-1 M
Diluted EPS total-1.67-3.4-4.75-7.09-8.08-13.3811.43-7.8-8.98
Diluted weighted shares outstanding22 M28 M33 M38 M46 M51 M53 M59 M59 M
GainOnSaleOfSecurity-102000.0
GeneralAndAdministrativeExpense10 M25 M39 M63 M-6 M-13 M-11 M-10 M-8 M
Gross operating profit90 M7 M1,114 M6 M8 M
Income before tax-34 M-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M
Income restructuring and M&A28 M
Interest income8000.0178000.01 M3 M20 M28 M10 M3 M14 M
MiscOtherSpecialCharges-9000.0-23000.0-35000.0-64000.022000.082000.0250000.0134000.015000.0
Net income from total operations-34 M-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M
NetIncomeCommonStockholders-36 M-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M
NetIncomeContinuousOperations-34 M-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M
NetNonOperatingInterestIncomeExpense8000.0178000.01 M3 M20 M28 M10 M3 M14 M
Operating income-34 M-95 M-160 M-273 M-393 M-708 M624 M-461 M-547 M
Operating income before depreciation (EBITDA)-34 M-94 M-159 M-270 M-372 M-678 M609 M-454 M-532 M
OperatingExpense-34 M-95 M-160 M-273 M-484 M-715 M-518 M-467 M-555 M
Other income net9000.023000.035000.064000.0-22000.0-82000.0-250000.0-134000.0-15000.0
OtherGandA10 M25 M39 M63 M-6 M-13 M-11 M-10 M-8 M
OtherOperatingExpenses-34 M-95 M-160 M-273 M-484 M400000.0565000.0553000.0813000.0
OtherunderPreferredStockDividend2 M
PreferredStockDividends2 M
RentAndLandingFees10 M25 M39 M63 M-6 M-10 M
Research & development expense24 M69 M121 M210 M282 M369 M293 M283 M326 M
ResearchExpense24 M69 M121 M210 M282 M369 M293 M283 M326 M
RestructringAndMnAIncome28 M
SalariesAndWages-3 M-15 M-23 M-36 M-102 M-153 M-96 M-105 M-62 M
Selling Gen & administrative expense10 M25 M39 M63 M201 M346 M197 M183 M228 M
SellingAndMarketingExpense201 M346 M197 M183 M228 M
SellingExpense201 M346 M197 M183 M228 M
Special income/charges-28 M
Total Income available for interest expense (EBIT)-34 M-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M
Total common shares outstanding26 M32 M37 M46 M47 M52 M58 M59 M60 M
Total net income-34 M-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M
Total ordinary shares60 M60 M60 M60 M60 M60 M60 M60 M60 M
Total revenues90 M7 M1,114 M6 M8 M
TotalExpenses-34 M-95 M-160 M-273 M-484 M-715 M-518 M-467 M-555 M
TotalRevenue90 M7 M1,114 M6 M8 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today